LÖFGREN’S SYNDROME: ASSESSMENT OF OUTCOMES

Download full text PDF
Issue: 
10
Year: 
2016

N. Savushkina; O. Egorova, Candidate of Medical Sciences; S. Glukhova, Candidate of Medical Sciences; Professor S. Radenska-Lopovok, MD; B. Belov, MD V.A. Nasonova Research Institute of Rheumatology, Moscow

The clinical features and outcomes of erythema nodosum were studied in patients with Löfgren’s syndrome.
Keywords: 
rheumatology
septal panniculitis
erythema nodosum
sarcoidosis
Löfgren’s syndrome
diagnosis
clinical presentations
outcomes
recurrent erythema nodosum

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Lazarus A. Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics // Dis. Mon. – 2009; 55: 649–60.
  2. Hanno R., Callen J. Sarcoidosis: a disorder with prominent cutaneous features and their interrelationship with systemic disease // Med. Clin. North. Am. – 1980; 64: 847–66.
  3. Mana J., Marcoval J. Skin manifestations of sarcoidosis // Presse Med. – 3. 2012; 41: 355–74.
  4. Parrish S., Turner J. Diagnosis of sarcoidosis // Dis. Mon. – 2009; 55: 4. 693–703.
  5. Mana J., Gomez-Vaquero C., Montero A. et al. Lofgren’s syndrome revisited: a study of 186 patients // Am. J. Med. – 1999; 107: 240–5.
  6. Löfgren S., Lundbäck H. The bilateral hilar lymphoma syndrome. A study of the relation to age and sex in 212 cases // Acta Med. Scand. – 1952; 142: 259–64.
  7. Mana J., Marcoval J. Erythema nodosum // Clin. Dermatol. – 2007; 25: 7. 288–94.
  8. Mañá J., Marcoval J., Graells J. et al. Cutaneous involvement in sarcoidosis. Relationship to systemic disease // Arch. Dermatol. – 1997; 133: 882–8.
  9. Paramothayan N., Jones P. Corticosteroids for pulmonary sarcoidosis // Cochrane Database Syst. Rev. – 2000; 2: CD001114
  10. Hunninghake G., Costabel U., Ando M. et al. ATS/ ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/ World Association of Sarcoidosis and other Granulomatous Disorders // Sarcoidosis Vasc. Diffuse Lung Dis. – 1999; 16 (2): 149–73.
  11. Chuchalin A.G., Avdeev S.N., Baranova O.P. i dr. Diagnostika i lechenie sarkoidoza (Federal'nye soglasitel'nye klinicheskie rekomendatsii) / Minzdrav Rossii. Rossijskoe respiratornoe obschestvo, 2014; s. 36–9.
  12. Ungprasert P., Carmona E., Utz J. et al. Epidemiology of Sarcoidosis 1946-12. 2013: A Population-Based Study // Mayo Clin. Proc. – 2016; 91 (2): 183–8.
  13. Tejera Segura B., Holgado S., Mateo L. et al. Löfgren syndrome: A study of 80 cases // Medicina Clinica. – 2014; 143 (4): 166–9
  14. Mana J., Salazar A., Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases // Respiration. – 1994; 61 (4): 219–25.
  15. Takada K., Ina Y., Noda M. et al. The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis // J. Clin. Epidemiol. – 1993; 46 (4): 359–66.
  16. Vizel' I.Ju., Shmelev E.I., Baranova O.P. i dr. Mul'titsentrovoj retrospektivnyj analiz sostojanija bol'nyh sarkoidozom s 10-letnim inter-valom nabljudenija // Klinicheskaja meditsina. – 2014; 92 (6): 28–34.